Molecular Diagnostics
Novel Nanosensing Technologies Developed for Exosome Detection and Profiling
Exosomes are extracellular vesicles (EVs) that are produced in the endosomal compartment of most eukaryotic cells. Liquid biopsy technologies have been developed to do high-throughput exosome protein profiling and point-of-care (POC) exosome analysis. More...20 Nov 2019
Blood Biomarkers Identify Individuals at Risk of Heart Attack or Stroke
A recent study found that elevated levels of high-sensitivity cardiac troponin T or NT-proBNP characterized individuals with elevated blood pressure (BP) or hypertension not currently recommended for anti-hypertensive medication who are at high risk for cardiovascular (CV) events such as heart attack or stroke. More...20 Nov 2019
Early-Onset Alzheimer's Mutation Possibly Mitigated by APOE Variant
Alzheimer's disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills, and, eventually, the ability to carry out the simplest tasks. In most people with Alzheimer's, symptoms first appear in their mid-60s. More...19 Nov 2019
Phoenix CPO Test Evaluated for Detection of Carbapenemase Producers
The use of nucleic acid amplification tests (NAAT) to identify rapidly Carbapenemase-Producing Organisms (CPO) from samples such as positive blood culture and stools is an alternative approach to establish rapidly an optimal empirical antibiotic therapy or for infectious control management. More...14 Nov 2019
Rapid Fluorescence Fingerprinting Assay for Identification of Synthetic Cannabinoid Receptor Agonists
A team of British researchers developed a rapid real-time, point-of-care test for the identification of synthetic cannabinoid receptor agonists (SCRAs), a class of illegal drugs known colloquilly as “Spice” or “K2”. More...14 Nov 2019
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Gold Member
Collection and Transport System
PurSafe Plus®
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
In Other News
Newly Identified Biomarker Distinguishes Potentially Aggressive Meningiomas
Rapid DNA Flow Technology Platform Detects Tick-Borne Bacterial Pathogens
Researchers Recommend the Membrane Protein Flotillin as a Biomarker for Alzheimer’s Disease
Inexpensive LAMP-Based Schistosomiasis Tests Developed
Chromosomal Abnormalities Associated with Recurrent Miscarriage
Use of Cell-free DNA Liquid Biopsy to Predict Glioblastoma Progression
Prostate Cancer Methylation Levels Linked to Epigenetic Profiles
Metabolomic Profiling Identifies ALL Patients at Risk for MRD and Cancer Relapse
Enterovirus D type 111 Genetically and Phenotypically Characterized
Whole-exome Sequencing Identifies Mysterious Pancreatitis Mutation
Metastatic Tumor Profiles Lead to Potential Treatment Targets
Full Analytical Data Validated for Target Selector ctDNA Assays
Blood and Urine Metabolic Biomarkers Monitor Short-term Dietary Changes
Large-Scale Schizophrenia Exome Sequencing Identifies New Risk Genes
Nasopharyngeal Pneumococcal Density Associated with Invasive Lung Disease
Post-Treatment Colon Cancer Recurrence Identified by ctDNA Detection
Degree of Amyloid-Beta Misfolding Is Predictor of Alzheimer’s Disease Risk
Rapid Immunoassay Shows Potential for Lyme Disease Diagnosis
Methods Explored for Gram-Negative Non-Fermentative Bacteria ID
Trial Finds High Analytical Performance in Whole-Genome Sequencing
Lynch Syndrome Screening by IHC Leads to Mutation Studies
Adhesive Tape Strips Offer an Alternative Biopsy Method for Diagnosis of Atopic Dermatitis
Serum Levels of Neurofilament Light Chain Distinguish FTLD
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.